Subcortical T1-Rho MRI Abnormalities in Juvenile-Onset Huntington's Disease

Alexander V Tereshchenko1, Jordan L Schultz1,2,3, Ansley J Kunnath4

  • 1Department of Psychiatry, Carver College of Medicine at the University of Iowa, Iowa City, IA 52242, USA.

Brain Sciences
|August 14, 2020
PubMed

Insights

Juvenile-onset Huntington's disease (JOHD) shows increased subcortical metabolic abnormalities. T1-Rho MRI revealed higher relaxation times in key brain regions, correlating with disease severity and motor deficits in JOHD patients.

Area of Science:

  • Neuroimaging
  • Neurodegenerative Diseases
  • Genetics

Background:

  • Huntington's disease (HD) is a fatal neurodegenerative disorder caused by CAG repeat expansion in the huntingtin gene.
  • Juvenile-onset Huntington's disease (JOHD) accounts for 5% of cases, presenting before age 21.
  • Subcortical metabolic changes are implicated in HD pathogenesis.

Purpose of the Study:

  • To measure subcortical metabolic abnormalities in JOHD participants using T1-Rho MRI.
  • To investigate the relationship between metabolic changes, brain volume, and clinical scores in JOHD.

Main Methods:

  • T1-Rho (T) MRI was employed to compare brain regions between 13 JOHD participants and 39 controls.
  • Region-of-interest analyses quantified differences in T relaxation times.
  • Correlation analyses assessed relationships between T, brain volume, and Universal Huntington's Disease Rating Scale (UHDRS) scores.

Main Results:

  • JOHD participants exhibited significantly increased mean T relaxation times in the caudate, putamen, globus pallidus, and thalamus compared to controls.
  • Elevated T relaxation times were associated with reduced brain volumes in these subcortical regions in JOHD.
  • Mean T relaxation times in these areas were directly proportional to UHDRS scores, indicating a correlation with disease severity and motor deficits.

Conclusions:

  • Subcortical metabolic abnormalities, detectable by T1-Rho MRI, are present in JOHD.
  • These metabolic changes are linked to brain volume reduction and clinical manifestations, including motor deficits.
  • T1-Rho MRI may serve as a potential biomarker for disease progression and severity in JOHD.